Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Sichuan Kelun-Biotech Biopharmaceutical divulges dipeptidyl peptidase 4 inhibitors

May 30, 2017

Valerion Therapeutics begins recruitment in phase I/II trial of VAL-1221

May 29, 2017

Protagonist Therapeutics commences phase I study of hepcidin mimetic peptide

May 26, 2017

Radius Health reports topline results from Tymlos extension trial

May 25, 2017

EMA committee recommends orphan drug designation for MK-0677

May 25, 2017

FDA and EMA accept submissions for UX-003 for mucopolysaccharidosis VII

May 24, 2017

Zealand reports phase IIa results for dasiglucagon in type 1 diabetes

May 23, 2017

ViaCyte cleared to begin trial of PEC-Direct in U.S. and Canada

May 23, 2017

Complete disease correction using gene therapy in novel model of muccopolysaccharidosis type IIID

May 23, 2017

MSD submits application in Japan for approval of combination drug for type 2 diabetes

May 22, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...